-
141
VCP regulates early tau seed amplification via specific cofactors
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
142
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
143
Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
Published 2025-02-01“…Translational Neurodegeneration…”
Get full text
Article -
144
SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer’s disease
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
145
Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
146
The transcription factor combination MEF2 and KLF7 promotes axonal sprouting in the injured spinal cord with functional improvement and regeneration-associated gene expression
Published 2025-02-01“…Molecular Neurodegeneration…”
Get full text
Article -
147
Disparate and shared transcriptomic signatures associated with cortical atrophy in genetic behavioral variant frontotemporal degeneration
Published 2025-02-01“…Molecular Neurodegeneration…”
Get full text
Article -
148
Loss of MEF2C function by enhancer mutation leads to neuronal mitochondria dysfunction and motor deficits in mice
Published 2025-02-01“…Molecular Neurodegeneration…”
Get full text
Article -
149
APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
150
Correction: CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
Published 2025-01-01“…Translational Neurodegeneration…”
Get full text
Article -
151
Lewy body diseases and the gut
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
152
Correction: Inflammasomes in neurodegenerative diseases
Published 2025-01-01“…Translational Neurodegeneration…”
Get full text
Article -
153
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
Published 2025-01-01“…Translational Neurodegeneration…”
Get full text
Article -
154
Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
155
Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD
Published 2025-02-01“…Molecular Neurodegeneration…”
Get full text
Article -
156
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
Published 2025-01-01“…Molecular Neurodegeneration…”
Get full text
Article -
157
Aging-associated sensory decline and Alzheimer’s disease
Published 2024-12-01“…Molecular Neurodegeneration…”
Get full text
Article -
158
Peripheral proteinopathy in neurodegenerative diseases
Published 2025-01-01“…Translational Neurodegeneration…”
Get full text
Article -
159
CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
Published 2024-12-01“…Translational Neurodegeneration…”
Get full text
Article -
160
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology
Published 2025-01-01“…Translational Neurodegeneration…”
Get full text
Article